Autolus Therapeutics (AUTL) Misses Q2 EPS by 4c

Autolus Therapeutics (NASDAQ: AUTL) reported Q2 EPS of ($0.26), $0.04 worse than the analyst estimate of ($0.22).

For earnings history and earnings-related data on Autolus Therapeutics (AUTL) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• 51Talk Online Education Group (COE) Reports Q1 EPS of $0.00
• Dollarama Inc. (DOL:CN) (DLMAF) PT Raised to Cdn$221 at BMO Capital